These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8347844)

  • 41. The distributional implications of using relative prices in DRG payment systems.
    Thorpe KE
    Inquiry; 1987; 24(1):85-95. PubMed ID: 2951338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhouse authorization center to improve reimbursement for outpatient chemotherapy infusions.
    Desai SS
    Am J Health Syst Pharm; 2011 May; 68(9):828-34. PubMed ID: 21515867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Dec; 67(251):79965-80184. PubMed ID: 12510665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fundamentals of the US Medicare physician reimbursement process.
    Woody IO
    J Am Coll Radiol; 2005 Feb; 2(2):139-50. PubMed ID: 17411784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The future of oncology? Come home, the oncology medical home.
    McAneny BL
    Am J Manag Care; 2013; 19(1 Spec No):cover, SP41-2. PubMed ID: 23461475
    [No Abstract]   [Full Text] [Related]  

  • 46. Medicare program; fee schedule for payment of ambulance services and revisions to the physician certification requirements for coverage of nonemergency ambulance services. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Feb; 67(39):9099-135. PubMed ID: 11868577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medicare program; replacement of reasonable charge methodology by fee schedules for parenteral and enteral nutrients, equipment, and supplies. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2001 Aug; 66(167):45173-7. PubMed ID: 11757567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An analysis of methods to reform Medicare payment for physician services.
    Sisk JE; McMenamin P; Ruby G; Smith ES
    Inquiry; 1987; 24(1):36-47. PubMed ID: 2951332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reimbursement for cancer treatment: coverage of off-label drug indications.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enteral nutrition reimbursement - the rationale for the policy: the US perspective.
    Parver AK; Mutinsky SE
    Nestle Nutr Workshop Ser Clin Perform Programme; 2009; 12():53-70. PubMed ID: 19858686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Payment for inpatient and outpatient health care professional services at non-departmental facilities and other medical charges associated with non-VA outpatient care. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2010 Dec; 75(242):78901-15. PubMed ID: 21166263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing the reimbursement crisis.
    Martin M
    Adm Radiol; 1992 Jul; 11(7):60, 62, 64. PubMed ID: 10121756
    [No Abstract]   [Full Text] [Related]  

  • 54. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 55. Should oncologists support the Affordable Care Act?
    Kantarjian H; Steensma D; Light D
    Lancet Oncol; 2013 Dec; 14(13):1258-9. PubMed ID: 24275127
    [No Abstract]   [Full Text] [Related]  

  • 56. Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2018; Medicare Shared Savings Program Requirements; and Medicare Diabetes Prevention Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2017 Nov; 82(219):52976-3371. PubMed ID: 29231695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Key factors impacting the delivery and financing of oncology care in the United States.
    Goldsmith PJ; Paivanas T
    J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
    [No Abstract]   [Full Text] [Related]  

  • 58. Payment for non-VA physician services associated with either outpatient or inpatient care provided at non-VA facilities--VA. Final rule.
    Fed Regist; 1998 Jul; 63(141):39514-5. PubMed ID: 10181513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2017 Therapy Services News: New Codes and Medicare Payment Increases.
    Schaum KD
    Adv Skin Wound Care; 2017 Mar; 30(3):106-108. PubMed ID: 28198741
    [No Abstract]   [Full Text] [Related]  

  • 60. Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.
    Kline RM; Muldoon LD; Schumacher HK; Strawbridge LM; York AW; Mortimer LK; Falb AF; Cox KJ; Bazell C; Lukens EW; Kapp MC; Rajkumar R; Bassano A; Conway PH
    J Oncol Pract; 2017 Jul; 13(7):e632-e645. PubMed ID: 28535101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.